Friday, 26 April 2024
Innovate Biopharmaceuticals Inc.
NASDAQ : INNT
0.5400 09 Mar 20 00:00 | Change: 0.25 | Open: 0.5500 | High: 0.5500 | Ask: 0.0000 | Volume: 274,700 |
Change(%): 31.65 | Prev: 0.7900 | Low: 0.5000 | Bid: 0.0000 | Avg vol: 0 |
01:22 | 8/3/18
GlobeNewswire
RALEIGH, N.C., March 07, 2018 (GLOBE NEWSWIRE) -- Innovate Biopharmaceuticals, Inc. (Nasdaq:INNT), a clinical stage biotechnology company focused on developing novel therapeutics for autoimmune and inflammatory diseases, announced company executives ...
more»
04:22 | 8/2/18
GlobeNewswire
RALEIGH, N.C., Feb. 07, 2018 (GLOBE NEWSWIRE) -- Innovate Biopharmaceuticals, Inc. (Nasdaq:INNT) a clinical stage biotechnology company focused on developing novel autoimmune and inflammation therapeutics, announced company executives are scheduled to ...
more»
05:30 | 31/1/18
GlobeNewswire
Innovate Biopharmaceuticals, Inc. (Nasdaq:INNT) a clinical stage biotechnology company focused on developing novel autoimmune and inflammation therapeutics, announced the completion of its merger (the “Merger”) with Monster Digital, Inc. today.
more»
There are currently no comments on this topic.
Be the first person to Add a Comment...
You must be a registered user to post a comment: REGISTER NOW
If you are already registered, please LOGIN NOW
|
Code | Last | Change |
COMP | 10,321 | 328 | | 3.08% |
DJI | 29,635 | 404 | | 1.34% |
SP500 | 3,583 | 87 | | 2.37% |
DAX | 12,438 | 82 | | 0.67% |
FTSE | 7,488 | 5 | | 0.07% |
NI225 | 22,420 | 408 | | 1.86% |
TWI | 67.27 | 0.00 | | 0.00% |